-
公开(公告)号:US20230140435A1
公开(公告)日:2023-05-04
申请号:US17906522
申请日:2021-03-16
摘要: A recombinant viral vector comprising an expression cassette which comprises a coding sequence for an shRNA inhibitor of vasohibin (VASH)-small vasohibin binding protein (SVBP) complex operably linked to regulatory sequences which direct expression thereof is provided. Further provided are compositions containing such viral vectors formulated for delivery to a human patient. Also provided are methods using these vectors and compositions for improving or stabilizing cardiac function.
-
2.
公开(公告)号:US20230148068A1
公开(公告)日:2023-05-11
申请号:US17982147
申请日:2022-11-07
发明人: Anant Madabhushi , Sara Arabyarmohammadi , Cai Yuan , Eliot G. Peyster , Kenneth B. Margulies , Michael D. Feldman , Priti Lal
CPC分类号: G06T7/0014 , A61B5/413 , G06T2207/20081 , G06T2207/20084 , G06T2207/30048
摘要: The present disclosure in some embodiments relates to a non-transitory computer-readable medium storing computer-executable instructions that, when executed, cause a processor to perform operations, including obtaining one or more digitized endomyocardial biopsy (EMB) images from a patient having had a heart transplant; extracting a plurality of histological features from the one or more digitized EMB images; and applying a machine learning predictive model to operate on the plurality of histological features to generate a prediction for the patient. The prediction includes a grade or a clinical trajectory associated with the patient.
-
公开(公告)号:US20230366891A1
公开(公告)日:2023-11-16
申请号:US18246604
申请日:2021-09-24
IPC分类号: G01N33/68
CPC分类号: G01N33/6857 , G01N2333/7051 , G01N2333/70517 , G01N2333/7155 , G01N2333/70514 , G01N2333/70532 , G01N2333/70596
摘要: Methods for predicting risk of heart transplant rejection are disclosed.
-
公开(公告)号:US20180326022A1
公开(公告)日:2018-11-15
申请号:US15959181
申请日:2018-04-21
IPC分类号: A61K38/48 , A61P9/04 , A61K48/00 , A61K31/365
CPC分类号: A61K38/48 , A61K31/165 , A61K31/365 , A61K31/4184 , A61K31/475 , A61K48/0066 , A61K2300/00 , A61P9/04 , C12Y304/17017 , C12Y603/02025
摘要: Described herein is a method for improving or stabilizing cardiac function by inhibiting tubulin carboxypeptidase (TCP). Also described herein is a method for treating heart failure in humans comprising dosing a patient with a therapeutic which interferes with detyrosinated microtubules in cardiomyocytes. Also provided are viral vectors which comprise a nucleic acid encoding a tubulin tyrosine ligase (TTL) gene under the control of regulatory elements direct expression thereof. Compositions are also provided which contain such viral vectors formulated for delivery to a human patient.
-
-
-